Previous close | 32.20 |
Open | 32.65 |
Bid | 32.30 x 51100 |
Ask | 32.41 x 25600 |
Day's range | 32.34 - 32.71 |
52-week range | 21.14 - 35.30 |
Volume | |
Avg. volume | 2,348,144 |
Market cap | 48.438B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | 32.67 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.29 (0.90%) |
Ex-dividend date | 08 May 2024 |
1y target est | N/A |
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.